Article info

Download PDFPDF

Clinical science
Subretinal coapplication of recombinant tissue plasminogen activator and bevacizumab for neovascular age-related macular degeneration with submacular haemorrhage
  1. Correspondence to Dr J Hillenkamp, Department of Ophthalmology, University Medical Center Schleswig-Holstein, Arnold-Heller Str 3, Haus 25, D-24105 Kiel, Germany; hillenka{at}hotmail.com
View Full Text

Citation

Treumer F, Klatt C, Roider J, et al
Subretinal coapplication of recombinant tissue plasminogen activator and bevacizumab for neovascular age-related macular degeneration with submacular haemorrhage

Publication history

  • Accepted August 3, 2009
  • First published November 27, 2009.
Online issue publication 
March 22, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.